Viewing Study NCT01974895


Ignite Creation Date: 2025-12-24 @ 2:15 PM
Ignite Modification Date: 2025-12-26 @ 12:58 AM
Study NCT ID: NCT01974895
Status: COMPLETED
Last Update Posted: 2018-09-07
First Post: 2013-10-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine GSK2282512A When Administered to Children From 6 to 35 Months of Age
Sponsor: GlaxoSmithKline
Organization: